Susquehanna International Group
RCEL icon

Susquehanna International Group’s Avita Medical RCEL Stock Holding History

Susquehanna International Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.9K Buy
+19,700
New +$82.7K ﹤0.01% 12489
2025
Q3 		– Sell
-11,800
Closed -$62.4K – 13641
2025
Q2 		$62.4K Buy
+11,800
New +$85.8K ﹤0.01% 12043
2024
Q4 		– Sell
-14,600
Closed -$157K – 13030
2024
Q3 		$157K Buy
+14,600
New +$137K ﹤0.01% 10706
2023
Q1 		– Sell
-46,600
Closed -$308K – 13322
2022
Q4 		$308K Sell
46,600
-7,500
-14% -$44.9K ﹤0.01% 9040
2022
Q3 		$285K Buy
+54,100
New +$334K ﹤0.01% 9925
2020
Q3 		– Sell
-13,700
Closed -$418K – 11044
2020
Q2 		$418K Buy
+13,700
New +$419K ﹤0.01% 7747

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's RCEL Position: Q4 2025 in Review

Susquehanna International Group sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 35,193 shares — an estimated $180K sold.

Susquehanna International Group first reported a position in RCEL in Q2 2020 and held it in 20 quarters. The position peaked at $3.21M in Q1 2023. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

  • Susquehanna International Group reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 35,193 Avita Medical shares in Q4 2025, an estimated $180K.
  • Susquehanna International Group first reported a position in Avita Medical in Q2 2020 and held it in 20 quarters.
  • Susquehanna International Group's Avita Medical position peaked at $3.21M in Q1 2023.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.